Penta has a history of running high-quality paediatric HIV clinical training since 2005, in collaboration with a range of partners from Africa, Latin America, Europe and Asia. In line with our scientific strategy, and to build on the success of the existing global PentaTr@ining platform, we are also developing teaching material in other key paediatric infectious diseases of concern. Penta is now actively engaged in clinical research in neonatal sepsis, antimicrobial resistance, hepatitis and fungal infections in paediatrics, and we plan to start delivering targeted training programmes on each of these topics from 2022 onwards.Registrations have now closed for our brand new interactive course PentaTr@ining: Fungal Infections in Paediatrics. Led by an expert international faculty, this exciting online programme kicked off on 19th September 2022 and will run until 15th December 2022. We are committed to tackling hepatic infection in children and to bring this issue to the attention of clinicians, researchers and industry alike. An estimated 354 million people worldwide live with hepatitis B or C, and for most, testing and treatment remain beyond reach. However, there remain striking knowledge gaps for paediatric hepatitis, despite several millions of children living with chronic HBV and HCV worldwide. A significant proportion these are also living with HIV. In December 2022, we plan to launch comprehensive new online course: PentaTr@ining: Viral Hepatitis in Children. In line with the WHO response, our goal is to address specific knowledge gaps in order to establish best practices for the management, care and treatment of children and adolescents living with viral hepatitis. Course registration is free of charge - sign up here today!
The World Health Organisation has declared Antimicrobial Resistance (AMR) as one of the top 10 global public health threats facing humanity, and it aims to launch the WHO ‘Essential Medicines List Antibiotic Book’ in 2022. This will provide global guidance on managing the most common bacterial infections in children and adults in both the community and hospital setting, including the choice of drug, dose, and duration. In an era when increasing levels of antibiotic resistance may impact the treatment of severe infections, this represents an opportunity to provide further training on the rationale for the WHO recommendations, discussion on how these could be locally adapted, and future ideas for implementation. Our Penta experts have identified the top 10 paediatric hospital and community infections amongst these. We are developing training modules within a child-centered teaching model to support the ongoing learning needs using innovative distance learning methods on our online training platform. Our brand new programme PentaTr@ining: AMR Online Course will kick-off in early 2023 so watch this space!